Holen Sie sich die Stockscreener-App
14.77
1.07%
-0.16
Handel nachbörslich:
14.77
Schlusskurs vom Vortag:
$14.93
Offen:
$15.14
24-Stunden-Volumen:
425.30K
Relative Volume:
1.73
Marktkapitalisierung:
$522.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.37%
1M Leistung:
-27.67%
6M Leistung:
-43.95%
1J Leistung:
+0.00%
1-Tages-Spanne:
$14.01
$15.61
1-Wochen-Bereich:
$14.01
$15.61
52-Wochen-Spanne:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Vergleichen Sie CBLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
14.77 | 522.60M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4 - MSN
Alliancebernstein L.P. Invests $532,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell wins FDA nod for algorithm to detect pediatric seizures - MedTech Dive
Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating - TipRanks
Vanguard Group Inc. Takes $18.02 Million Position in CeriBell (NASDAQ:CBLL) - Defense World
CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm - MSN
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - markets.businessinsider.com
Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithm - TipRanks
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm - marketscreener.com
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric - GlobeNewswire
Groundbreaking FDA Approval: Ceribell's AI Now Detects Seizures in Children Within Minutes - Stock Titan
Corebridge Financial Inc. Buys Shares of 6,122 CeriBell (NASDAQ:CBLL) - Defense World
Norges Bank Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
CeriBell (NASDAQ:CBLL) Shares Gap Up – Still a Buy? - Defense World
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Ceribell braces for tariff impact on margins By Investing.com - Investing.com Canada
CeriBell's Stock Climbs As Tariff Relief Extends To 2025 - Finimize
Sector Update: Health Care - TradingView
CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4 - MarketScreener
William Blair maintains Ceribell Outperform amid tariff concerns By Investing.com - Investing.com Canada
Canaccord maintains Ceribell stock buy rating, $33 target By Investing.com - Investing.com South Africa
William Blair maintains Ceribell Outperform amid tariff concerns - Investing.com Australia
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Canaccord maintains Ceribell stock buy rating, $33 target - Investing.com
Ceribell, Inc.: Strategic Resilience and Financial Health Amid Market Challenges - TipRanks
Ceribell braces for tariff impact on margins - Investing.com Australia
Data-Based Insights About Ceribell Inc (CBLL) - stocksregister.com
Ceribell, Inc. Addresses Impact of New U.S. Tariffs - TipRanks
CeriBell addresses impact of new U.S. tariffs on Chinese imports - grafa.com
institutional investors of CeriBell, Inc. (NASDAQ:CBLL) must be disappointed after last week's 40% drop - simplywall.st
Ceribell, Inc.: Strategic Maneuvers Boost Gross Margin Amid Tariff Challenges, Supporting Buy Rating - TipRanks
Ceribell, Inc.: Strong Financial Position and Strategic Management Justify Buy Rating Amid Tariff Challenges - TipRanks
CeriBell, Inc.Common Stock (NQ: CBLL - FinancialContent
With 49% stake, CeriBell, Inc. (NASDAQ:CBLL) seems to have captured institutional investors' interest - Yahoo Finance
CeriBell's IPO Lockup Ends April 9Here's Why We're Shorting It Today (NASDAQ:CBLL) - Seeking Alpha
CeriBell (NASDAQ:CBLL) Receives $32.60 Average PT from Brokerages - Defense World
CeriBell (NASDAQ:CBLL) Coverage Initiated by Analysts at LADENBURG THALM/SH SH - Defense World
Ladenburg Thalmann Initiates Coverage of CeriBell (CBLL) with Buy Recommendation - Nasdaq
This Lattice Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Ladenburg Thalmann Initiates CeriBell at Buy With $32 Price Target - marketscreener.com
Critical Analysis: CeriBell (NASDAQ:CBLL) versus NeurAxis (NASDAQ:NRXS) - Defense World
Reviewing IRIDEX (NASDAQ:IRIX) & CeriBell (NASDAQ:CBLL) - Defense World
CeriBell’s (NASDAQ:CBLL) Lock-Up Period To Expire on April 9th - Defense World
Critical Comparison: CeriBell (NASDAQ:CBLL) and InMode (NASDAQ:INMD) - Defense World
Charles Schwab Investment Management Inc. Invests $2.50 Million in CeriBell (NASDAQ:CBLL) - Defense World
Bank of New York Mellon Corp Purchases New Holdings in CeriBell (NASDAQ:CBLL) - Defense World
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Es liegen keine Finanzdaten für Ceribell Inc (CBLL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):